As of June 2022 Pacific Biosciences has a market cap of $1.05 Billion. This makes Pacific Biosciences the world's 4241th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2022 | $1.25 B | -72.11% |
2021 | $4.51 B | -7.07% |
2020 | $4.85 B | 517.07% |
2019 | $0.78 B | -29.21% |
2018 | $1.11 B | 262.27% |
2017 | $0.30 B | -12.83% |
2016 | $0.35 B | -66.48% |
2015 | $1.05 B | 81.19% |
2014 | $0.57 B | 67.21% |
2013 | $0.34 B | 262.99% |
2012 | $0.09 B | -37.78% |
2011 | $0.15 B | -81.75% |
2010 | $0.84 B |
On Jun 28th, 2022 the market cap of Pacific Biosciences was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Thermo Fisher Scientific TMO | $208.76 B | 19,632.46% | ๐บ๐ธ USA |
![]() General Electric GE | $70.07 B | 6,523.94% | ๐บ๐ธ USA |
![]() Illumina ILMN | $29.15 B | 2,655.80% | ๐บ๐ธ USA |
![]() PerkinElmer
PKI | $17.89 B | 1,591.49% | ๐บ๐ธ USA |
![]() Luminex LMNX | $1.75 B | 65.42% | ๐บ๐ธ USA |
![]() NanoString Technologies NSTG | $0.59 B | -43.49% | ๐บ๐ธ USA |